EXHIBIT 10.29 CONSULTING AGREEMENT THIS AGREEMENT (this "Agreement") is entered into as of November 29, 2001 by and between Endorex Corporation, a Delaware Corporation located at 28101 Ballard Drive, Suite F, Lake Forest, IL 60045, (the "Company"),...Consulting Agreement • April 1st, 2002 • Dor Biopharma Inc • Pharmaceutical preparations • Illinois
BY AND BETWEEN ENDOREX CORPORATION AND MICHAEL S. ROSENEmployment Agreement • April 1st, 2002 • Dor Biopharma Inc • Pharmaceutical preparations • Illinois
BY AND BETWEEN ENDOREX CORPORATION AND COLIN BIEREmployment Agreement • April 1st, 2002 • Dor Biopharma Inc • Pharmaceutical preparations • Illinois
RECITALSNoncompetition and Nonsolicitation Agreement • April 1st, 2002 • Dor Biopharma Inc • Pharmaceutical preparations • Illinois
EXHIBIT 10.24 October 18, 2001 Mr. Peter Kash Senior Managing Director Paramount Capital, Inc. 787 Seventh Ave. New York, New York 10019 Dear Mr. Kash: With respect to our prior telephonic agreement regarding the role of Mr. Martin Kratchman and...Success Fee Agreement • April 1st, 2002 • Dor Biopharma Inc • Pharmaceutical preparations
With respect to our prior telephonic agreement regarding the role of Mr. Martin Kratchman and yourself as financial advisors to Endorex Corporation regarding (1) the introduction of Corporate Technology Development, Inc. ("CTD") to Endorex in 2000 and (2) ongoing assistance to Endorex in the acquisition of CTD, I would like to confirm that Endorex will, as a "success fee", issue to you and Mr. Kratchman in the aggregate 100,000 options to purchase Endorex common stock (the "Options"). The Options will be issued upon completion of Endorex's acquisition of CTD and stockholder approval of an amendment to Endorex's Amended and Restated 1995 Omnibus Incentive Plan (the "Plan") to increase the number of shares of stock available for issuance thereunder. This will be the total compensation for all financial advisory services of you and Mr. Kratchman to Endorex.
RECITALSTermination and Release Agreement • April 1st, 2002 • Dor Biopharma Inc • Pharmaceutical preparations • New York
